This study is in progress, not accepting new patients
Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCLA
- Dates
- study startedcompletion around
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Aura Biosciences
- Links
- Aura Biosciences
- ID
- NCT04417530
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- About 22 people participating
- Last Updated